Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in L'aquila – page 2

32 clinical trials in L'aquila, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
L'aquila at a glance
32
clinical trials
  • Not yet recruiting0
  • Research sites0
Type of trial
Recruitment status
Quick filters

32 trials in L'aquila

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Nemolizumab
  • Sponsor:Galderma S.A.

Migraine+2

Not recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Atogepant
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Vitiligo

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Pfizer Inc.

Dermatitis atopic

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Ischaemic stroke+2

Not recruiting
Investigational
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Asundexian
  • Sponsor:Bayer AG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Dapagliflozin
  • Sponsor:Novo Nordisk A/S
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Amlitelimab
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Dermatitis atopic

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Rocatinlimab
  • Sponsor:Amgen Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Alopecia areata

Not recruiting
Investigational
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Upadacitinib
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in L'aquila

What the registry says about research in the country

01 Dermatological Studies

Current clinical trials focus on innovative treatments for atopic dermatitis and prurigo nodularis, evaluating new therapeutic approaches for managing severe skin conditions.

  • Moderate to severe atopic dermatitis treatment
  • Prurigo nodularis management
  • Alopecia areata interventions

Research emphasizes long-term efficacy and safety of treatments like upadacitinib and amlitelimab.

02 Neurological Research

Studies concentrate on migraine prevention and treatment, including medication overuse headache and innovative approaches using eptinezumab and atogepant.

  • Chronic and episodic migraine management
  • Stroke prevention and treatment
  • Intracerebral hemorrhage interventions

Trials explore both acute treatment options and preventive therapies for neurological conditions.

03 Autoimmune Conditions

Research focuses on treating Sjögren's Syndrome and related autoimmune disorders, evaluating novel therapeutic approaches for systemic manifestations.

  • Systemic disease management
  • Long-term treatment efficacy
  • Symptom control strategies

Studies aim to improve quality of life for patients with chronic autoimmune conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.